UCLA’s Prostate Cancer Program offers the latest and most advanced care for both early and late stage prostate cancer. Our physicians are trained in urologic oncology and have been consistently ranked among the top prostate cancer practitioners in the United States. Additionally, our doctors are part of The UCLA Institute of Urologic Oncology (the "IUO") and its multidisciplinary team of world-renowned physicians and scientists who are working together to personalize patient care and to develop revolutionary treatments for men diagnosed with prostate cancer.
Prostate cancer is marked by an uncontrolled (malignant) growth of cells in the prostate gland. The prostate is the walnut-sized gland in men, located just below the bladder and in front of the rectum, surrounding the urethra – the tube that carries urine out of the bladder. The prostate produces and stores fluid that helps to make semen, and is involved in regulating bladder control.
More information about prostate cancer >
There are often no symptoms of early stage prostate cancer, so early detection and screening are critical.
More information about prostate cancer symptoms >
UCLA Urologists follow the American Urological Association’s guidelines for prostate cancer screening.
Prostate cancer screening consists of:
At UCLA’s Prostate Cancer Program, targeted biopsy is also being used to diagnose prostate cancer. Targeted biopsy refers to using advanced MRI and PET imaging techniques to identify areas of the prostate suspicious for cancer, and then directly biopsying them. UCLA was one of the first institutions to develop and offer targeted biopsies and has published many of the seminal works on this technique.
More information about prostate cancer diagnosis, grading and staging >
UCLA urologists and UCLA Prostate Cancer Program doctors have been pioneers in developing new innovations and technologies leading to safer and more effective treatments for patients with prostate cancer, using a multidisciplinary, translational approach to care. As a result, treatment plans are individualized to each patient’s cancer grade and stage as well as current state of health.
The UCLA Prostate Cancer Program offers a broad range of innovative diagnostic and treatment options to patients who have been diagnosed with prostate cancer, including:
Clinical trials are essential for developing new methods of preventing, diagnosing and treating prostate cancer. The UCLA Prostate Cancer Program offers patients access to ground-breaking experimental drugs in its Clinical Trials Program that allows patients to receive tomorrow’s approved drugs today.
The UCLA Prostate Cancer program is committed to rapidly translating basic research from the laboratory to the clinic in order to advance care for men with prostate cancer and, as a result, is one of only two centers in the Western United States to be recognized by the National Cancer Institute as a Specialized Program of Research Excellence (SPORE).